⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28437217 | 1.00 | — | — | |
| SCHEMBL5314812 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL4621231 | 0.97 | — | — | |
| SCHEMBL27633258 | 0.78 | — | — | |
| SCHEMBL4194876 | 0.77 | — | — | |
| SCHEMBL25330082 | 0.77 | — | — | |
| SCHEMBL19557132 | 0.77 | — | — | |
| SCHEMBL17479965 | 0.77 | — | — | |
| SCHEMBL5314714 | 0.77 | — | — | |
| SCHEMBL3129970 | 0.77 | APLNR (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12247036-B2 | Tricyclic compounds for the treatment of cancer | HOFFMANN-LA ROCHE INC. (US) | 2025-03-11 | — | — | US | claimed |
| US-20240417410-A1 | TRICYCLIC COMPOUNDS FOR THE TREATMENT OF CANCER | HOFFMANN-LA ROCHE INC. (US) | 2024-12-19 | — | — | US | claimed |
| CN-107207472-B | Inhibitors of AKT kinase | 卑尔根生物股份公司 | 2020-08-14 | — | — | CN | claimed |
| CN-109286041-A | Electrolyte and secondary lithium battery | 宁德时代新能源科技股份有限公司 | 2019-01-29 | — | — | CN | claimed |
| EP-3240784-A2 | INHIBITORS OF AKT KINASE | BerGenBio ASA (NO) | 2017-11-08 | — | — | EP | claimed |
| CN-104193645-B | Preparation method of chiral dimethyl cyclopropyl carboxamide | 上海应用技术学院 | 2017-02-01 | — | — | CN | claimed |
| WO-2016102672-A2 | PHARMACEUTICALLY ACTIVE COMPOUNDS | BERGENBIO AS (NO) | 2016-06-30 | — | — | WO | claimed |
| EP-2699547-B1 | 5-(PHENYL/PYRIDINYL-ETHINYL)-2-PYRIDINE/2-PYRIMIDINE-CARBORXAMIDES AS MGLUR5 MODULATORS | HOFFMANN LA ROCHE (CH) | 2015-03-04 | — | — | EP | claimed |
| CN-104193645-A | Preparation method of chiral dimethyl cyclopropyl carboxamide | SHANGHAI INST TECHNOLOGY | 2014-12-10 | — | — | CN | claimed |
| US-8906930-B2 | Quinazoline derivatives | MERCK PATENT GMBH (DE) | 2014-12-09 | — | — | US | claimed |
| EP-2504314-A1 | QUINAZOLINE DERIVATIVES | Merck Patent GmbH (DE) | 2012-10-03 | — | — | EP | claimed |
| US-20120238582-A1 | QUINAZOLINE DERIVATIVES | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-09-20 | — | — | US | claimed |
| WO-2011061609-A2 | PROCESSES FOR THE PREPARATION OF CILASTATIN | RANBAXY LABORATORIES LIMITED (IN) | 2011-05-26 | — | — | WO | claimed |
| WO-2011060873-A1 | QUINAZOLINE DERIVATIVES | MERCK PATENT GMBH (DE) | 2011-05-26 | — | — | WO | claimed |
| CN-1824795-A | Optical selective screening process for amidase | UNIV ZHEJIANG POLYTECHNIC (CN) | 2006-08-30 | — | — | CN | claimed |
| JP-5076391-A | — | — | None | — | — | JP | disclosed |
| JP-5236993-A | — | — | None | — | — | JP | disclosed |
| JP-H05236993-A | GENETIC ENGINEERING PRODUCTION OF S-(+)-2,2-DIMETHYLCYCLOPROPANECARBOXAMIDE BY MICROORGANISM | LONZA AG | 1993-09-17 | — | — | JP | disclosed |
| JP-H0576391-A | BIOTECHNOLOGICAL PRODUCTION OF S-(+)-2, 2-DTMETHYLCYCLOPROPANECARBOXAMIDE | LONZA AG | 1993-03-30 | — | — | JP | disclosed |
| US-4288621-A | Substituted 2,2-dimethylcyclopropaneamides | ZOECON CORPORATION (US) | 1981-09-08 | — | — | US | disclosed |